204 related articles for article (PubMed ID: 16298002)
1. The impact of introducing intensity modulated radiotherapy into routine clinical practice.
Miles EA; Clark CH; Urbano MT; Bidmead M; Dearnaley DP; Harrington KJ; A'Hern R; Nutting CM
Radiother Oncol; 2005 Dec; 77(3):241-6. PubMed ID: 16298002
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)].
Marchal C; Lapeyre M; Beckendorf V; Aletti P; Haslé E; Dubois JB; Maingon P; Bensadoun RJ; Le Prise E; Lartigau E; Carrie C; Dubray B; Marchesi V; Ailleres N; Naudy S; Marcie S; Manens JP; Mazurier J; Ginestet C; Chauvin F; Pommier P; Gerard JP; Carrere MO
Cancer Radiother; 2004 Nov; 8 Suppl 1():S121-7. PubMed ID: 15679257
[TBL] [Abstract][Full Text] [Related]
4. Time trial: a prospective comparative study of the time-resource burden for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers.
Murthy V; Gupta T; Kadam A; Ghosh-Laskar S; Budrukkar A; Phurailatpam R; Pai R; Agarwal J
J Cancer Res Ther; 2009; 5(2):107-12. PubMed ID: 19542666
[TBL] [Abstract][Full Text] [Related]
5. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
[TBL] [Abstract][Full Text] [Related]
6. Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement.
Adams EJ; Convery DJ; Cosgrove VP; McNair HA; Staffurth JN; Vaarkamp J; Nutting CM; Warrington AP; Webb S; Balyckyi J; Dearnaley DP
Radiother Oncol; 2004 Jan; 70(1):1-10. PubMed ID: 15036846
[TBL] [Abstract][Full Text] [Related]
7. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
[TBL] [Abstract][Full Text] [Related]
8. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
9. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort.
Guadagnolo BA; Liu CC; Cormier JN; Du XL
Cancer; 2010 Jul; 116(14):3505-12. PubMed ID: 20564123
[TBL] [Abstract][Full Text] [Related]
11. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult.
Ho KF; Fowler JF; Sykes AJ; Yap BK; Lee LW; Slevin NJ
Acta Oncol; 2009; 48(3):431-9. PubMed ID: 18781445
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy.
Bouchard M; Nadeau S; Gingras L; Raymond PE; Beaulieu F; Beaulieu L; Fortin A; Germain I
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1343-50. PubMed ID: 18294780
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
15. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer.
Krayenbuehl J; Davis JB; Ciernik IF
Radiother Oncol; 2006 Nov; 81(2):151-7. PubMed ID: 17055095
[TBL] [Abstract][Full Text] [Related]
16. [Intensity modulated radiotherapy (IMRT) in France: The boost of the national funding for the new expensive innovative technologies (STIC 2001 and 2002)].
Marchal C; Bensadoun RJ; Haslé E; Lapeyre M; Carrere MO; Gérard JP
Cancer Radiother; 2003 Nov; 7 Suppl 1():44s-48s. PubMed ID: 15124543
[TBL] [Abstract][Full Text] [Related]
17. Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique.
Ganswindt U; Paulsen F; Corvin S; Hundt I; Alber M; Frey B; Stenzl A; Bares R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):347-55. PubMed ID: 17236960
[TBL] [Abstract][Full Text] [Related]
18. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer.
Price RA; Hannoun-Levi JM; Horwitz E; Buyyounouski M; Ruth KJ; Ma CM; Pollack A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):583-92. PubMed ID: 16966000
[TBL] [Abstract][Full Text] [Related]
19. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls.
Mendenhall WM; Amdur RJ; Palta JR
J Clin Oncol; 2006 Jun; 24(17):2618-23. PubMed ID: 16763274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
